{"disease":{"id":"seizure-generalized","name":"seizure generalized"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03059329","title":"Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adult Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures","phase":"","overall_status":"COMPLETED","enrollment_count":3809,"lead_sponsor_name":"Eisai Co., Ltd.","has_results":false},{"nct_id":"NCT03822741","title":"Etiology and Treatment of Neonatal Seizure","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Children's Hospital of Fudan University","has_results":false},{"nct_id":"NCT07287163","title":"Clinical Trial of Vormatrigine in Adult Patients With Epilepsy","phase":"PHASE3","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":700,"lead_sponsor_name":"Praxis Precision Medicines","has_results":false},{"nct_id":"NCT01463306","title":"A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":605,"lead_sponsor_name":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","has_results":true},{"nct_id":"NCT03059381","title":"Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adolescence Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures","phase":"","overall_status":"COMPLETED","enrollment_count":519,"lead_sponsor_name":"Eisai Co., Ltd.","has_results":false},{"nct_id":"NCT06960811","title":"Epileptic Psychoses and Their Link With Ictal Emotions and Consciousness","phase":"","overall_status":"COMPLETED","enrollment_count":117,"lead_sponsor_name":"Central Hospital, Nancy, France","has_results":false},{"nct_id":"NCT06657378","title":"A Study to Evaluate the Safety of Fycompa Injection in Participants With Partial-Onset Seizures or Primary Generalized Tonic- Clonic Seizures","phase":"","overall_status":"RECRUITING","enrollment_count":110,"lead_sponsor_name":"Eisai Co., Ltd.","has_results":false},{"nct_id":"NCT03288129","title":"Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Eisai Inc.","has_results":true},{"nct_id":"NCT05339126","title":"RNS System LGS Feasibility Study","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":24,"lead_sponsor_name":"NeuroPace","has_results":false},{"nct_id":"NCT03443388","title":"Novel Helmet Design in Patients With Seizures","phase":"NA","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Michael A. Gelfand, MD, PhD","has_results":true}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}